Pseudo-Pseudo Meigs’ Syndrome-Like Presentation Associated with Primary Sjögren’s Syndrome: A Case Report Authors: Jixiang Xun, Xiaohan Liu, Bohan Chang, Xue Wang, Cheng Peng, Pingting Yang, Xudong Liu Published: 2026 ABSTRACT AbstractObjectiveTo explore the clinical diagnostic methods and therapeutic outcomes for rheumatologic and immunologic disorders characterized by “polypleural effusion with elevated CA12-5”, aiming to avoid misdiagnosis and mistreatment due to similar symptoms.MethodsA retrospective analysis was conducted on the clinical data of a 56-year-old female patient. Multidisciplinary consultation (gynecology, thoracic medicine, rheumatology and immunology), imaging studies, laboratory tests, and pathological biopsy results were combined to establish a definitive diagnosis. After diagnosis, the patient received combined treatment with corticosteroids and immunosuppressants, with dynamic evaluation of clinical efficacy.ResultsSystematic examinations ruled out gynecological tumors, tuberculosis, and other diseases. Based on abnormal rheumatologic and immunologic markers, organ involvement, and treatment response, the patient was diagnosed with primary Sjögren’s syndrome, pseudo-pseudo Meigs’ syndrome (PPMS,Tjalma syndrome), interstitial pneumonia and so on. After treatment with methylprednisolone combined with hydroxychloroquine and mycophenolate mofetil, CA12-5 levels significantly decreased, polypleural effusion gradually resolved, and the condition remained stable over the long term.ConclusionPrimary Sjögren’s syndrome may be complicated by PPMS, with PPMS as the initial clinical manifestation. Early multidisciplinary collaboration is crucial to avoid misdiagnosis, and the corticosteroid combined with immunosuppressant treatment has been proved that it was associated with clinical improvement.Keywords: Sjögren’s syndrome, pseudomegaly syndrome, pleural effusion, CA12-5, immunosuppressants Introduction Pseudo-pseudo Meigs’ syndrome (PPMS), also known as Tjalma syndrome, is classically characterized by pleural effusion, ascites and elevated CA12-5 in patients with systemic lupus erythematosus (SLE), after exclusion of tumors, tuberculosis and other causes of serosal effusion.1 Because most reported PPMS cases have occurred in SLE or lupus-spectrum disease, identifying a PPMS-like presentation in another autoimmune disease requires careful exclusion of SLE overlap, malignancy and infection. PPMS should be distinguished from Meigs’ syndrome, pseudo-Meigs’ syndrome and Meige syndrome. Meigs’ syndrome refers to the combination of a benign ovarian tumor, ascites and pleural effusion that resolves after tumor resection.2 Pseudo-Meigs’ syndrome describes ascites and pleural effusion associated with malignant or other pelvic or abdominal tumors, with improvement after treatment of the underlying tumor.3 Meige syndrome, by contrast, is a neurologic movement disorder characterized by blepharospasm and oromandibular dystonia and is unrelated to serosal effusion syndromes. Primary Sjögren’s syndrome (pSS) is a systemic autoimmune disease characterized by lymphocytic infiltration of exocrine glands, typically causing dry eyes and dry mouth, and it may also involve extraglandular organs.4 The present case is unusual because the initial clinical problem was PPMS-like polyserositis with elevated CA-125 rather than typical sicca symptoms. We therefore report the diagnostic process, treatment response and limitations of causal inference in this patient. Methods This is a retrospective single-patient case report following the CARE reporting guidelines. Clinical data, laboratory results, imaging and pathological records were retrospectively extracted from the electronic medical record system of The First Hospital of China Medical University. The study was approved by The Medical Science Research Ethics Committee of The First Hospital of China Medical University (Ethics Department [2025] No. 807). Written informed consent was obtained from the patient for treatment, data review and publication of de‑identified clinical materials and images, complying with the Declaration of Helsinki. Ascites was collected via abdominal paracentesis for cytology. Ultrasound‑guided omental needle biopsy and minor labial salivary gland biopsy were performed. Biopsy tissues were fixed in 4% neutral buffered formalin, paraffin‑embedded and processed for hematoxylin‑eosin staining and immunohistochemistry. Mycobacterium tuberculosis PCR was tested on omental biopsy specimens. Routine laboratory tests, inflammatory markers, immunoglobulins, CA12-5 and autoantibodies were detected using hospital-validated clinical immunoassays following manufacturer protocols, with reference ranges from our local laboratory. Imaging assessments included pelvic-abdominal ultrasound, contrast-enhanced abdominal CT, pulmonary HRCT and salivary gland ECT, interpreted by experienced radiologists. Primary Sjögren’s syndrome was diagnosed according to the 2016 ACR/EULAR classification criteria. After exclusion of malignancy and tuberculosis, pseudo-pseudo Meigs’ syndrome was confirmed. The patient received intravenous methylprednisolone followed by tapering oral methylprednisolone combined with hydroxychloroquine and mycophenolate mofetil. Serial laboratory and imaging follow-up was performed to evaluate treatment response. No statistical analysis was conducted for this single-case report; serial clinical-laboratory outcomes were presented descriptively and illustrated in Figure 1. (A) Two months after discharge,CA12-5 decreased to 29.4 U/mL. (B). IgG to16.01 g/L. (C). Anti-cardiolipin antibody IgG to 19.2 CU. (D). MPO-ANCA to 4.8 CU. (E). PR3-ANCA to 9.4 CU. (F). Anti-β2-glycoprotein 1 antibody IgA to 16.2 CU. Case Presentation A 56-year-old female patient was admitted in May 2025 due to dull pain in the left upper abdomen for two months. Approximately two months prior to admission, the patient developed dull pain in the left upper abdomen without obvious triggering causes. She consulted the Department of Obstetrics and Gynecology, where ultrasonography (Figure 2A and B) and contrast-enhanced abdominal CT (Figure 2C) revealed a hypoechoic mass in the both side of adnexal region, massive ascites, pleural effusion, hydropericardium and thickened omental. Abdominal paracentesis was performed, and 200mL of pale yellow ascites was drained for routine analysis. Routine ascites examination found no cancer cells. The level of serum CA12-5 was significantly elevated as 459.00U/mL. Ultrasound-guided omental needle biopsy revealed non-necrotizing granulomatous lesions with a negative PCR test for tuberculosis (Figure 2D). (A) strip-shaped hypoechoic area is visible beside the right ovary (4.64×0.96cm); (B). The right upper quadrant omentum with a maximum thickness of 3.68 cm, appearing hyperechoic and dense, along with pelvic and peritoneal effusion (7.84cm deep in the pelvis); (C). Contrast-enhanced abdominal CT reveals massive ascites; (D). Pathological Diagnosis: (Right Upper Abdominal Omentum): Non-necrotizing granulomatous lesions. Immunohistochemistry and tuberculosis PCR are recommended for auxiliary diagnosis. Immunohistochemistry: CK (focal +), CD68 (+), Vimentin (+). Tuberculosis PCR: Negative; (E). Small salivary gland biopsy:minor acinar atrophy, focal lymphocyte aggregation, and dilated ducts within the lobules, with a focal index of 2 and CM grade 3. (A focus was defined as an aggregate containing ≥50 mononuclear lymphocytes. Immunohistochemistry showed IgG4 (-) and IgG (+); (F-G). polyserositis. To rule out the presence of rheumatic disease, the patient came to our department and was hospitalized. The blood tests revealed positive rheumatic and immunological parameters, including ANA, Ro-52, anticardiolipin antibody-IgG, anti-β2-glycoprotein 1 antibody-IgA, MPO-ANCA, PR3-ANCA, KL-6, elevated level of ESR, CRP, Immunoglobulin(Ig)-G, IgA, negative of myositis-related antibodies. A diagnosis of rheumatic immune disease was considered. Anti-double-stranded DNA antibody and anti-Smith antibody were negative, and no clinical features fulfilling SLE classification criteria were identified. The patient presented without xerostomia or xerophthalmia, the classic manifestations of SS, and tested negative for anti-SSA and anti-SSB antibodies. Labial gland biopsy revealed acinar atrophy, focal lymphocytic infiltration, and intralobular duct ectasia, with a focus score of 2 and Chisholm–Mason grade 3. The patient’s complement levels were within normal limits. Urinalysis showed isolated leukocytosis, while all other parameters remained unremarkable. The patient was previously hospitalized in the Department of Gynecology of our hospital, with discharge diagnoses of high-grade squamous intraepithelial lesion of the cervix (HSIL/CIN 2) and human papillomavirus (HPV) infection (genotypes 16, 53 and 58). As the patient presented with positive of anti-Ro-52 antibody and serum IgG levels, further examinations of pSS was performed. Salivary gland ECT (Emission Computed Tomography) showed the excretory function of parotid glands was decreased after acid stimulation. The uptake function of the bilateral submandibular glands was decreased, with excretion after acid stimulation. The spontaneous excretory function of the salivary glands was decreased, the minor salivary gland biopsy was performed, and the result confirmed the diagnosis of pSS (Figure 2E). To screen for involved organs, HRCT of the lungs was performed, revealing a small amount of pericardial effusion, and a small amount of left pleural effusion (Figure 2F). The final diagnosis was Primary Sjögrens syndrome, Pseudo-pseudo Meigs’ syndrome, interstitial pneumonia, pleural effusion, undetermined ovarian mass, non-necrotizing omental granuloma. The patient was initially treated with intravenous infusion methylprednisolone 40 mg per day. For maintenance therapy after discharge, oral methylprednisolone 6 tablets per day (gradually tapered) was prescribed, combined with hydroxychloroquine (200 mg in the morning and 100 mg in the evening, twice daily) and mycophenolate mofetil 0.75 g twice daily. After 3 days of treatment: CA12-5 decreased from 459.00 U/mL to 194.00 U/mL, and the depth of pelvic and peritoneal effusion reduced from 6cm to 2 cm. One month after discharge, ascites completely resolved, and general condition improved. Two months after discharge,CA12-5 decreased to 29.4 U/mL (Figure 1A), IgG to16.01 g/L (Figure 1B), anti-cardiolipin antibody IgG to 19.2 CU (Figure 1C), MPO-ANCA to 4.8 CU (Figure 1D), PR3-ANCA to 9.4 CU (Figure 1E), anti-β2-glycoprotein 1 antibody IgA to 16.2 CU (Figure 1F). Gynecological ultrasound showed no significant free fluid dark area in the pelvis, and the right ovarian adnexal hypoechoic strip was smaller than before (3.06×0.93 cm). Hormone dosage was reduced to 2 tablets per day. Treatment with hydroxychloroquine and mycophenolate mofetil was continued, and the patient’s condition remained stable. Discussion Serositis occurs in approximately 12% of patients with SLE, typically manifesting as pleuritis and pericarditis.5 PPMS is also commonly observed in patients with SLE. This patient presented with a PPMS-like triad of refractory ascites, pleural effusion and markedly elevated CA-125, but she fulfilled diagnostic features of pSS and did not have a confirmed diagnosis of ovarian malignancy or tuberculosis in the available evaluation. Therefore, this case suggests that pSS should be considered in the differential diagnosis of PPMS-like polyserositis.6 However, the association should be interpreted cautiously and does not prove that pSS directly caused PPMS. PPMS should be differentiated from Meigs’ syndrome (MS) and pseudo‑Meigs’ syndrome (PMS). MS is characterized by benign ovarian tumor, ascites, and pleural effusion (predominantly right‑sided), with complete resolution of effusions following surgical resection of the ovarian tumor.2 PMS is characterized by malignant pelvic or abdominal tumors accompanied by ascites and pleural effusion, which resolve after tumor removal. The differential diagnosis is clinically important because polyserositis with elevated CA-125 may mimic ovarian malignancy, tuberculosis, Meigs’ syndrome or pseudo-Meigs’ syndrome, potentially leading to misdiagnosis or unnecessary surgery.3 A concise comparison of the major differential diagnoses is provided in Table 1. Table 1Differential Diagnosis of Polyserositis with Elevated CA12-5 in This CaseDiagnosisTypical FeaturesFindings in This PatientInterpretationMeigs’ syndromeBenign ovarian tumor with ascites and pleural effusion; effusions resolve after tumor resection.Adnexal hypoechoic lesion was present, but no benign ovarian tumor was confirmed and effusions improved without tumor resection.Not established; continued gynecologic follow-up is required.Pseudo-Meigs’ syndromeMalignant or other pelvic/abdominal tumor with ascites and pleural effusion.Ascitic fluid cytology showed no malignant cells; omental biopsy did not show malignancy; adnexal lesion decreased during follow-up.Malignancy was not supported by available data, but surveillance remains necessary.PPMS/Tjalma syndromeSLE-associated ascites, pleural effusion and elevated CA-125 after exclusion of tumor and tuberculosis.PPMS-like triad was present; pSS was supported by salivary gland dysfunction and minor salivary gland biopsy.Suggests a PPMS-like presentation associated with pSS; SLE overlap should be explicitly excluded with full serology and systemic evaluation.Tuberculosis/peritoneal tuberculosisAscites, granulomatous inflammation and elevated CA-125 may mimic malignancy.Omental biopsy showed non-necrotizing granulomatous lesions; tuberculosis PCR was negative.Not supported by PCR, but incomplete exclusion requires follow-up.Other granulomatous diseaseGranulomatous lesions may occur in infectious, inflammatory or malignant conditions.Non-necrotizing omental granuloma remained an unresolved finding.Requires continued clinical correlation and surveillance.Autoimmune serositis associated with pSSSystemic autoimmune disease with extraglandular involvement may cause serosal inflammation.Positive autoimmune markers, abnormal salivary gland ECT, minor salivary gland biopsy findings and response to immunosuppressive therapy supported autoimmune inflammation.Most consistent working explanation, but causality cannot be proven from a single case. Differential Diagnosis of Polyserositis with Elevated CA12-5 in This Case Owing to the rarity of this condition, the precise pathophysiological mechanism of the associated serositis remains incompletely elucidated. The prevailing hypothesis suggests that the syndrome results from uncontrolled inflammatory responses in the serosa, which may be caused by lymphoplasmacytic infiltration, deposition of immune complexes in the peritoneum with local inflammation, or peritoneal vasculitis, leading to pleural and peritoneal effusions.7 Pleural effusion may also arise from the mechanical passage of ascitic fluid into the pleural space via diaphragmatic defects, intercellular spaces, or lymphatic channels. CA12‑5 is a high‑molecular‑weight glycoprotein mainly expressed in coelomic epithelial cells, including pleura, peritoneum, pericardium, fallopian tube epithelium, and ovarian epithelium. Serum levels are normally low but increase significantly when these cells are stimulated by inflammation, injury, or neoplasia.8 CA12‑5 is mainly used as a biomarker for ovarian cancer screening. Elevated levels can be detected in ovarian cancer, benign gynecological diseases, tuberculosis, and various autoimmune diseases.9 Especially in SLE and Sjögren’s syndrome with serositis, inflammatory mediators including interferon‑γ, IL‑1β, and VEGF activate mesothelial cells, resulting in massive release of CA12‑5 and markedly elevated serum levels.10,11 In the present patient, the striking elevation of CA12‑5 was most likely related to severe inflammatory activity in Sjögren’s syndrome. Uncontrolled severe inflammation may be both a cause and a risk factor for PPMS. Therefore, controlling inflammation may represent a strategy to prevent the development of PPMS. Previously, Ahmed O et al reported cases characterized predominantly by PPMS in the setting of SLE/SS overlap syndrome in their published article.12 Clinicians should distinguish this entity from the aforementioned syndrome during clinical diagnosis and management. In clinical practice, polyserositis with elevated serum CA-125 is commonly observed in gynecological tumors, tuberculosis and connective tissue diseases. In this case, the patient was initially suspected of having a gynecological tumor because of the adnexal lesion and elevated CA-125. Through multidisciplinary collaboration involving gynecology, thoracic surgery, rheumatology and immunology, ascitic fluid assessment, omental biopsy and tuberculosis PCR did not support malignancy or tuberculosis. Combined with positive autoantibodies, abnormal salivary gland function and pathological changes in the labial glands, pSS was diagnosed, and unnecessary surgery was avoided. Treatment with corticosteroids, hydroxychloroquine and mycophenolate mofetil was followed by rapid improvement of effusions and normalization of CA-125, consistent with an autoimmune inflammatory component.13 This report has several limitations. First, the follow-up period remains short, and the adnexal lesion had decreased but had not completely resolved. Second, the omental biopsy showed non-necrotizing granulomatous lesions; although tuberculosis PCR was negative and cytology did not reveal malignant cells, tuberculosis, malignancy and other granulomatous diseases require continued clinical and imaging surveillance. Third, because this is a single case, the findings support a possible association between pSS and a PPMS-like presentation rather than proving causality or definitive treatment efficacy. Conclusion In summary, for patients presenting with “polyserous effusion with elevated CA12-5”, multidisciplinary collaborative evaluation should be emphasized. After ruling out tumors and tuberculosis, timely completion of rheumatologic and immunological examinations is essential to avoid misdiagnosis and mistreatment. For PPMS associated with Sjögrens syndrome, treatment primarily involves a combination of corticosteroids and immunosuppressants, which can effectively control the condition. Funding Statement The authors declare this study was supported by the Natural Science Foundation of Liaoning Province (2024-MSLH-553) and (2025JH2/101800351). Data Sharing Statement The datasets used and/or analyzed during the current study are available from the corresponding authors Pingting Yang and Xudong Liu on reasonable request. Ethics Statement The studies involving humans were approved by The Medical Science Research Ethics Committee of the First Hospital of China Medical University (Ethics Department [2025] No. 807). The studies were conducted in accordance with the local legislation and institutional requirements and complied with the Declaration of Helsinki. The participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article. This case report was prepared in accordance with the CARE reporting guidelines. Author Contributions JXX: Writing – review & editing, Formal Analysis, Resources,Validation, Software, Methodology, Writing – original draft, Supervision, Investigation, Visualization, Conceptualization, Project administration. XHL: Visualization, Resources, Validation, Project administration, Formal Analysis, Methodology, Writing – review & editing, Investigation, Conceptualization, Writing – original draft, Software,Supervision, Funding acquisition. BHC: Validation, Conceptualization, Project administration, Methodology, Writing –review & editing, Supervision, Investigation, Writing – original draft, Funding acquisition, Resources, Visualization, Formal Analysis, Software. XW: Methodology, Investigation, Software, Writing – review & editing, Conceptualization,Visualization, Resources, Writing – original draft, Validation,Formal Analysis, Project administration. CP: Methodology,Visualization, Validation, Writing – review & editing. PTY: Funding acquisition, Resources, Project administration,Visualization, Supervision, Formal Analysis, Writing – review & editing, Investigation, Software. XDL: Visualization, Investigation, Conceptualization, Validation, Funding acquisition, Project administration, Methodology, Formal Analysis, Supervision, Writing – review & editing, Software,Resources. All authors took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work. Disclosure The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. References Associated Data Data Availability Statement The datasets used and/or analyzed during the current study are available from the corresponding authors Pingting Yang and Xudong Liu on reasonable request.